SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038877
Filing Date
2019-08-09
Accepted
2019-08-09 16:05:00
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv526214_10q.htm 10-Q 811177
2 EXHIBIT 10.1 tv526214_ex10-1.htm EX-10.1 48371
3 EXHIBIT 31.1 tv526214_ex31-1.htm EX-31.1 12958
4 EXHIBIT 31.2 tv526214_ex31-2.htm EX-31.2 12572
5 EXHIBIT 32.1 tv526214_ex32-1.htm EX-32.1 4752
6 EXHIBIT 32.2 tv526214_ex32-2.htm EX-32.2 4597
  Complete submission text file 0001144204-19-038877.txt   5048909

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mbio-20190630.xml EX-101.INS 1214860
8 XBRL TAXONOMY EXTENSION SCHEMA mbio-20190630.xsd EX-101.SCH 43545
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbio-20190630_cal.xml EX-101.CAL 46606
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbio-20190630_def.xml EX-101.DEF 186574
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20190630_lab.xml EX-101.LAB 324995
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20190630_pre.xml EX-101.PRE 303811
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 191012978
SIC: 2834 Pharmaceutical Preparations